Wang et al. [23], similar to our study, demonstrated that chemo-immunotherapy (vinorelbine, cisplatin, and lentinan) resulted in upregulated IFN-γ and TNF-α production in patients with non-small-cell lung cancer. Here, IFNG is linked to non-small cell lung carcinoma.